Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scanbalt Clinical Research Network Project Focuses On Diabetes

25.08.2006
ScanBalt Clinical Research Network project successfully finished

The ScanBalt Clinical Research Network project, launched in March 2005, was successfully finished in April 2006. The ScanBalt Clinical Research Network was a pilot project, funded by Nordic innovation Center, which overall aim was to give added value to the vision of ScanBalt BioRegion: to be a globally competitive meta-region. Two main objectives of the project were:

1. to map the resources and competencies of clinical research in the region;

2. to identify the persons for continued activities in the network.

As a result of the project completed mapping of competencies and resources in the field of pre-clinical research, clinical trials, and mobile ICT solutions for conducting clinical trials was carried out. Based on this a database with search engine for competencies and partners was created (available at www.scanbalt.org/factfile-c). The general result of the project indicated that all parties involved found the clinical network important and useful. On the other hand it was not easy to find persons that are willing to take active role in setting up really working network. Substantial efforts and financial resources are needed in order create a fully working network structure. CRO-s seems to have a theoretical conflict of interest as investigator network are often main proprietary asset of the company.

Nevertheless, it has been widely recognized the ScanBalt Bioregion countries and regions to be too small on their own to be able to supply large enough trial groups. Number of governments (for example UK) has initiated strategic projects to improve their position on the global clinical research arena. Mutual cooperation based on the well organized network will potentially improve ScanBalt Bioregions position in clinical research industry.

The vision of the follow-up proof of concept project to the ScanBalt Clinical Research Network pilot project is to set up a working patient recruitment network in the ScanBalt region embracing one disease area - diabetes. The new organization will be based on the interconnection network of academic clinical research infrastructures, hospitals and industry.

This diabetes network has to provide effective and efficient infrastructure for prompt recruitment and clinical trial management: legally and organizationally sound tool for electronic selection of patients from different clinical databases and research sites, efficient system for obtaining approvals by ethics committees and obtaining informed consent from participants, appropriate management IT tool for conducting clinical trials and securing the quality of trials.

The Estonian Genome Project Foundation in cooperation with Tartu Biotechnology Park and Sahlgrenska University Hospital has started to select partners as well to design general outline for this proof of principle project. The proof of concept project, if successful, can be stepwise extended to other therapeutic areas as well as to widen the partnership with other European regions.

Elise Kvarnstroem | alfa
Further information:
http://www.scanbalt.org
http://www.scanbalt.org/clinres

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Why might reading make myopic?

18.07.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>